Your browser doesn't support javascript.
loading
Assessing the impact of antiemetic guideline compliance on prevention of chemotherapy-induced nausea and vomiting: Results of the nausea/emesis registry in oncology (NERO).
Aapro, Matti; Caprariu, Zoe; Chilingirov, Petio; Chrápavá, Marika; Curca, Razvan-Ovidiu; Gales, Laurentia; Grigorescu, Alexandru C; Huszno, Joanna; Karlínová, Bára; Kellnerová, Renata; Malejcíková, Miroslava; Marinca, Mihai; Petru, Edgar; Pluzanski, Adam; Pokorná, Petra; Pribulova, Zuzana; Rubach, Maryna; Steger, Gunther G; Tesarová, Petra; Valekova, Lubica; Yordanov, Nicolay; Walaszkowska-Czyz, Anna.
Affiliation
  • Aapro M; Oncology Department, Genolier Cancer Center, Clinique de Genolier, Genolier, Switzerland. Electronic address: maapro@genolier.net.
  • Caprariu Z; Oncomed, Timisoara, Romania.
  • Chilingirov P; Complex Oncology Center, Stara Zagora, Stara Zagora, Bulgaria.
  • Chrápavá M; Institute of Biostatistics and Analyses, Ltd., Brno, Czech Republic.
  • Curca RO; Emergency County Hospital, Alba Iulia, Romania.
  • Gales L; Department of Medical Oncology, Clinical Hospital for Nephrology "Carol Davila" Bucharest, Bucharest, Romania; Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
  • Grigorescu AC; Department of Medical Oncology, Clinical Hospital for Nephrology "Carol Davila" Bucharest, Bucharest, Romania.
  • Huszno J; Radiotherapy Department, Genetic Outpatient Clinic, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland.
  • Karlínová B; Institute of Biostatistics and Analyses, Ltd., Brno, Czech Republic.
  • Kellnerová R; Medical Department, Angelini Pharma, Ceská republika s.r.o., Brno, Czech Republic.
  • Malejcíková M; Clinical Oncology Department, National Cancer Institute, Bratislava, Slovak Republic.
  • Marinca M; Grigore T. Popa University of Medicine and Pharmacy, Regional Oncology Institute, Iasi, Romania.
  • Petru E; Department of Obstetrics and Gynecology, Medical University of Graz, Graz, Austria.
  • Pluzanski A; Lung Cancer and Chest Tumors Department, Maria Sklodowska Curie National Research Institute of Oncology, Warsaw, Poland.
  • Pokorná P; Department of Oncology, 2(nd) Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic.
  • Pribulova Z; Department of Oncology, East Slovakian Institute of Oncology, Kosice, Slovak Republic.
  • Rubach M; Chemotherapy Day Ward, Maria Sklodowska Curie National Research Institute of Oncology, Warsaw, Poland.
  • Steger GG; Division of Oncology, Department of Internal Medicine I and Gaston H. Glock - Research Center, Medical University of Vienna, Vienna, Austria.
  • Tesarová P; Department of Oncology, 1st Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
  • Valekova L; University Hospital Martin, Martin, Slovak Republic.
  • Yordanov N; Department Medical Oncology, Medical University - Sofia, Affiliation - Vratsa, Comprehensive Cancer Center - Vratsa, Vratsa, Bulgaria.
  • Walaszkowska-Czyz A; Szpital Swietej Rodziny, Oddzial Onkologiczny, Warsaw, Poland.
Eur J Cancer ; 166: 126-133, 2022 05.
Article in En | MEDLINE | ID: mdl-35290913
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiemetics / Antineoplastic Agents Type of study: Clinical_trials / Guideline / Observational_studies Limits: Humans Language: En Journal: Eur J Cancer Year: 2022 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiemetics / Antineoplastic Agents Type of study: Clinical_trials / Guideline / Observational_studies Limits: Humans Language: En Journal: Eur J Cancer Year: 2022 Document type: Article